By Amina Niasse NEW YORK, Feb 7 (Reuters) - Companies looking to sell weight-loss drugs directly to consumers, including Novo ...
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal ...
A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes, or another condition. And we expect that number to rise now that ...
If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering ...